Gene M Dubowchik Selected Research

Gene M Dubowchik Research Topics

Disease

11	Migraine Disorders (Migraine) 01/2021 - 08/2008
8	Neoplasms (Cancer) 01/2018 - 01/2002
2	Alzheimer Disease (Alzheimer's Disease) 02/2016 - 05/2015
1	Pain (Aches) 11/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Mood Disorders (Mood Disorder) 02/2016
1	Bipolar Disorder (Manic Depressive Psychosis) 05/2015
1	Stroke (Strokes) 05/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2003
1	Melanoma (Melanoma, Malignant) 02/2003
1	Carcinoma (Carcinomatosis) 07/2002

Drug/Important Bio-Agent (IBA)

8	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2021 - 04/2012
8	Calcitonin Gene-Related PeptideIBA 01/2021 - 08/2008
4	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2021 - 08/2008
4	Immunoconjugates (Immunoconjugate)IBA 01/2018 - 01/2002
4	Pharmaceutical PreparationsIBA 05/2003 - 01/2002
4	AntigensIBA 05/2003 - 06/2002
2	Glycogen Synthase Kinase 3IBA 02/2016 - 05/2015
2	piperidineIBA 06/2013 - 12/2012
2	4- (8- fluoro- 2- oxo- 1,2- dihydroquinazolin- 3(4H)- yl)- N- (3- (7- methyl- 1H- indazol- 5- yl)- 1- oxo- 1- (4- (piperidin- 1- yl)piperidin- 1- yl)propan- 2- yl)piperidine- 1- carboxamideIBA 04/2012 - 08/2008
2	Monoclonal AntibodiesIBA 05/2003 - 07/2002
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2002 - 07/2002
1	rimegepant sulfateIBA 11/2019
1	Ado-Trastuzumab EmtansineIBA 01/2018
1	Brentuximab VedotinIBA 01/2018
1	NeuropeptidesIBA 02/2016
1	Glycogen Synthase (Synthase I)IBA 05/2015
1	N- (3- (7- methyl- 1H- indazol- 5- yl)- 1- (4- (1- methylpiperidin- 4- yl)- 1- oxopropan- 2- yl))- 4- (2- oxo- 1,2- dihydroquinolin- 3- yl)piperidine- 1- carboxamideIBA 06/2013
1	Tryptamines (Triptans)IBA 06/2013
1	AmidesIBA 04/2012
1	pyridineIBA 04/2012
1	BMS-846372IBA 04/2012
1	AntibodiesIBA 05/2003
1	Gemtuzumab (Mylotarg)FDA Link 05/2003
1	CalicheamicinsIBA 05/2003
1	AcidsIBA 02/2003
1	ProdrugsIBA 02/2003
1	Proteins (Proteins, Gene)FDA Link 02/2003
1	Peptides (Polypeptides)IBA 09/2002
1	DipeptidesIBA 07/2002
1	serum P-component (CIt)IBA 07/2002
1	Cathepsin BIBA 01/2002
1	CamptothecinIBA 01/2002

Therapy/Procedure

4	Therapeutics 01/2020 - 05/2003